Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies. The ACTG 187 and 199 study teams.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples